Bromperidol is a potent butyrophenone neuroleptic antipsychotic primarily indicated for the management of schizophrenia. Laboratories supporting the pharmaceutical industry utilize this collection of bromperidol… Read more








Bromperidol is a potent butyrophenone neuroleptic antipsychotic primarily indicated for the management of schizophrenia. Laboratories supporting the pharmaceutical industry utilize this collection of bromperidol reference standards, metabolites, and degradation products to ensure rigorous quality control and accurate analytical testing. The category encompasses pharmacopeial and non-pharmacopeial impurities, such as decanoate variants and specific synthetic byproducts, which are essential for precise impurity profiling during drug development and stability studies. Furthermore, the inclusion of stable isotope labelled compounds, such as bromperidol-d4, facilitates reliable quantification through mass spectrometry by serving as internal standards in complex bioanalytical matrices. By employing these high-quality materials, researchers can effectively perform method validation, monitor potential degradation pathways, and meet regulatory requirements for safety and efficacy in neuroleptic drug production.